These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38553613)

  • 21. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
    Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
    Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
    Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA.
    Pan X; Huang B; Ma Q; Ren J; Liu Y; Wang C; Zhang D; Fu J; Ran L; Yu T; Li H; Wang X; Yang F; Liang C; Zhang Y; Wang S; Ren J; Li W; Wang Y; Xiao B
    Clin Transl Med; 2022 Jul; 12(7):e994. PubMed ID: 35876041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling.
    Zheng D; Ning J; Deng H; Ruan Y; Cheng F
    J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
    Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
    FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis.
    Zhang MX; Zhang LZ; Fu LM; Yao HH; Tan L; Feng ZH; Li JY; Lu J; Pan YH; Shu GN; Li PJ; Tang YM; Liao ZY; Wei JH; Chen W; Guo JP; Luo JH; Chen ZH
    Oncogene; 2021 Sep; 40(37):5639-5650. PubMed ID: 34321604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase.
    Yang YC; Lin YW; Lee WJ; Lai FR; Ho KH; Chu CY; Hua KT; Chen JQ; Tung MC; Hsiao M; Wen YC; Chien MH
    J Biomed Sci; 2023 Aug; 30(1):68. PubMed ID: 37580757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
    Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
    J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
    Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
    Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression.
    Wang S; Wang K; Yue D; Yang X; Pan X; Kong F; Zhao R; Bie Q; Tian D; Zhu S; He B; Bin Z
    Br J Cancer; 2024 Sep; 131(4):641-654. PubMed ID: 38906969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
    Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
    Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
    [No Abstract]   [Full Text] [Related]  

  • 34. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
    Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
    Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
    J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma.
    Jiang N; Niu G; Pan YH; Pan W; Zhang MF; Zhang CZ; Shen H
    EBioMedicine; 2020 Mar; 53():102692. PubMed ID: 32113161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
    Xiao W; Wang C; Chen K; Wang T; Xing J; Zhang X; Wang X
    EBioMedicine; 2020 Jan; 51():102622. PubMed ID: 31901870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.